Comparison of the Innofluor® certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation

Sara Baldelli, Alberto Crippa, Roberta Gabrieli, Roberto Fiocchi, Norberto Perico, Simona Merlini, Cosimo Ottomano, Dario Cattaneo

Research output: Contribution to journalArticle

Abstract

Objectives: Therapeutic monitoring of everolimus with chromatographic methods (HPLC) enabled effective immunosuppression while limiting the incidence of drug-related adverse events. A fluorescence polarization immunoassay (FPIA) has been recently developed for the assessment of everolimus levels. The present study was designed to evaluate FPIA performance and to compare it to HPLC. Design and methods: The performance of HPLC and FPIA was initially tested using drug-free whole blood spiked with different amount of everolimus concentrations and, subsequently, by analyzing 113 trough blood samples from heart transplant recipients chronically given everolimus as part of their immunosuppressive regimen. Results: Inaccuracy and imprecision of both methods were below 15%. The correlation between everolimus concentrations and measured FPIA and HPLC was good, with a Pearson coefficient of 0.9118. The FPIA gave a mean overestimation of 24.3% as compared with HPLC. As additional analysis, cross-reactivity ranging from 85.4% to 138.0% was found with sirolimus, an immunosuppressant with a chemical structure close to everolimus. Conclusion: The FPIA demonstrated acceptable performance for therapeutic drug monitoring of everolimus, and is a viable alternative to HPLC-based methods.

Original languageEnglish
Pages (from-to)1152-1159
Number of pages8
JournalClinical Biochemistry
Volume39
Issue number12
DOIs
Publication statusPublished - Dec 2006

Keywords

  • Everolimus
  • Heart transplantation
  • HPLC
  • Immunoassay
  • Method comparison
  • Sirolimus

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Comparison of the Innofluor® certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation'. Together they form a unique fingerprint.

  • Cite this